Nicolas WENG KAN

Menna helps UK small businesses become smarter about money, engage more with their finances and grow faster by reducing their costs and improving access to affordable funding.

Veridian Ventures is an angel syndicate offering carefully curated investment opportunities to our network of Investor Members. Veridian’s partners invest in each opportunity introduced to Veridian’s Members. At Veridian we focus on innovative early-stage companies in the UK with strong growth and profit potential. Our steady flow of quality deals, combined with a methodical and thorough diligence process, enable us to identify superior investment opportunities. One of the core values of the Veridian partners is to challenge and support ambitious and talented entrepreneurs, helping them to turn their potential into results. Our partners draw from a wealth of expertise, connections and investment experience to help start-ups raise capital, develop growth strategies and navigate the challenges of a rapidly growing business.

At Mendelian, our mission is to make rare diseases our priority. We have an amazing team who have built software, which enables doctors to help patients earlier, by finding the undiagnosed. Did you know that rare diseases are not actually rare? More rare diseases are life-threatening condition that are collectively common. In fact, 1 in 17 of us will be affected by a rare disease in our lifetime. This is comparable to common diseases such as diabetes and asthma. Rare disease symptoms often develop gradually and in different organ systems. This means patients present to different doctors for seemingly independent reasons making these diseases difficult to diagnose. On average, rare disease patients experience 3 misdiagnoses, visit 5 different doctors and wait over 4 years before receiving a diagnosis in the UK. In the past decade, undiagnosed rare diseases have cost the NHS in excess of £3.4 billion.

Menna helps UK small businesses become smarter about money, engage more with their finances and grow faster by reducing their costs and improving access to affordable funding.

Veridian Ventures is an angel syndicate offering carefully curated investment opportunities to our network of Investor Members. Veridian’s partners invest in each opportunity introduced to Veridian’s Members. At Veridian we focus on innovative early-stage companies in the UK with strong growth and profit potential. Our steady flow of quality deals, combined with a methodical and thorough diligence process, enable us to identify superior investment opportunities. One of the core values of the Veridian partners is to challenge and support ambitious and talented entrepreneurs, helping them to turn their potential into results. Our partners draw from a wealth of expertise, connections and investment experience to help start-ups raise capital, develop growth strategies and navigate the challenges of a rapidly growing business.

At Mendelian, our mission is to make rare diseases our priority. We have an amazing team who have built software, which enables doctors to help patients earlier, by finding the undiagnosed. Did you know that rare diseases are not actually rare? More rare diseases are life-threatening condition that are collectively common. In fact, 1 in 17 of us will be affected by a rare disease in our lifetime. This is comparable to common diseases such as diabetes and asthma. Rare disease symptoms often develop gradually and in different organ systems. This means patients present to different doctors for seemingly independent reasons making these diseases difficult to diagnose. On average, rare disease patients experience 3 misdiagnoses, visit 5 different doctors and wait over 4 years before receiving a diagnosis in the UK. In the past decade, undiagnosed rare diseases have cost the NHS in excess of £3.4 billion.